FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 44 filers reported holding FINCH THERAPEUTICS GROUP INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $19 | -47.2% | 48,669 | -34.3% | 0.00% | – |
| Q4 2022 | $36 | -100.0% | 74,110 | -38.7% | 0.00% | – |
| Q3 2022 | $202,000 | -22.0% | 120,907 | +32.8% | 0.00% | – |
| Q2 2022 | $259,000 | +105.6% | 91,042 | +620.2% | 0.00% | – |
| Q4 2021 | $126,000 | -86.3% | 12,642 | -80.6% | 0.00% | -100.0% |
| Q2 2021 | $917,000 | -72.1% | 65,141 | -68.4% | 0.00% | -50.0% |
| Q1 2021 | $3,282,000 | – | 206,297 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avenir Management Company, LLC | 55,445 | $472,946 | 1.27% |